Skip to main content
Top
Published in: Pathology & Oncology Research 3/2012

01-07-2012 | Research

A Proposed New Technique in Prostate Cancer Tissue Bio-Banking: Our Experience with a New Protocol

Authors: Luca Carmignani, Stefano Picozzi, Stefano Casellato, Giorgio Bozzini, Carlo Marenghi, Alberto Macchi, Luca Lunelli, Barbara Rubino, Claudio Clemente

Published in: Pathology & Oncology Research | Issue 3/2012

Login to get access

Abstract

The aim of our study, beyond validating a method of collecting and storing biological samples from patients with prostate cancer, was to validate an innovative biopsy method for the creation of a biobank of prostatic frozen tissues. Patients referred to our hospital between November 2008 and March 2010 to undergo radical prostatectomy were invited to participate in the study. Each patient’s data were stored in two databases (personal information and clinical database) while samples of urine, blood and its derivatives, fresh material and formalin-processed tissue were stored in a correlated biobank. The proposed method for collecting fresh material was to take samples of the neoplastic tissue by carrying out targeted biopsies in the area indicated by the biopsy mapping as the site of the malignancy, under manual palpation to identify the neoplastic nodule. The site of sampling was marked by an injection of India ink. 55 patients agreed to participate in the study. In 43 cases biopsies were correct, with a mean of 48% of core involved by tumour (range, 10–90%). Overall the tumour detection rate was 78.2%. The protocol for collecting biological material and the new method for collecting fresh tissue reduce internal steps and staff involved, thereby reducing all those variables that cause heterogeneity of material and changes in its quality. This process provides high quality, low cost material for research on prostate cancer. The features of the collection protocol mean that the protocol can also be used in non-academic centres with only limited research funds.
Literature
2.
go back to reference Melamed J, Datta MW, Becich MJ et al (2004) The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers. Clin Cancer Res 10:4614–21PubMedCrossRef Melamed J, Datta MW, Becich MJ et al (2004) The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers. Clin Cancer Res 10:4614–21PubMedCrossRef
3.
go back to reference Bova GS, Fox WM, Epstein JI (1993) Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod Pathol 6:201–7PubMed Bova GS, Fox WM, Epstein JI (1993) Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod Pathol 6:201–7PubMed
4.
go back to reference Bonavina L, Laface L, Picozzi S et al (2010) Proposal of a punch biopsy protocol as a pre-requisite for the establishment of a tissue bank from resected esophageal tumors. Pathol Oncol Res 16:457–60PubMedCrossRef Bonavina L, Laface L, Picozzi S et al (2010) Proposal of a punch biopsy protocol as a pre-requisite for the establishment of a tissue bank from resected esophageal tumors. Pathol Oncol Res 16:457–60PubMedCrossRef
5.
go back to reference Greene FL, Page DL, Fleming ID et al (2002) AJCC Cancer Staging Manual, 6th edn. Springer, New York, NY Greene FL, Page DL, Fleming ID et al (2002) AJCC Cancer Staging Manual, 6th edn. Springer, New York, NY
6.
go back to reference Bosso N, Chinello C, Picozzi SC et al (2008) Human urine biomarkers of renal cell carcinoma evaluated by ClinProt. Proteomics Clin Appl 2:1036–46PubMedCrossRef Bosso N, Chinello C, Picozzi SC et al (2008) Human urine biomarkers of renal cell carcinoma evaluated by ClinProt. Proteomics Clin Appl 2:1036–46PubMedCrossRef
7.
go back to reference Hulmes JD, Bethea D, Ho K et al (2004) An investigation of plasma collection, stabilization, and storage procedures for proteomic analysis of clinical samples. Clinical Proteomics 1:17–31CrossRef Hulmes JD, Bethea D, Ho K et al (2004) An investigation of plasma collection, stabilization, and storage procedures for proteomic analysis of clinical samples. Clinical Proteomics 1:17–31CrossRef
8.
go back to reference Thongboonkerd V (2007) Proteomics of human body fluids: principles, methods, and applications. Humana Press Inc., New JerseyCrossRef Thongboonkerd V (2007) Proteomics of human body fluids: principles, methods, and applications. Humana Press Inc., New JerseyCrossRef
9.
go back to reference Gore JL, Shariat SF, Miles BJ et al (2001) Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165:1554–9PubMedCrossRef Gore JL, Shariat SF, Miles BJ et al (2001) Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165:1554–9PubMedCrossRef
10.
go back to reference Etzioni R, Penson DF, Legler JM et al (2002) Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94:981–990PubMedCrossRef Etzioni R, Penson DF, Legler JM et al (2002) Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94:981–990PubMedCrossRef
11.
go back to reference Johansson JE, Andren O, Andersson SO et al (2004) Natural history of early, localized prostate cancer. JAMA 291:2713–9PubMedCrossRef Johansson JE, Andren O, Andersson SO et al (2004) Natural history of early, localized prostate cancer. JAMA 291:2713–9PubMedCrossRef
12.
go back to reference Schroeder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Eng J Med 360:1320–8CrossRef Schroeder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Eng J Med 360:1320–8CrossRef
14.
go back to reference Milanes-Yearsley M, Hammond ME, Pajak TF et al (2002) Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups. Mod Pathol 15:1366–73PubMedCrossRef Milanes-Yearsley M, Hammond ME, Pajak TF et al (2002) Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups. Mod Pathol 15:1366–73PubMedCrossRef
Metadata
Title
A Proposed New Technique in Prostate Cancer Tissue Bio-Banking: Our Experience with a New Protocol
Authors
Luca Carmignani
Stefano Picozzi
Stefano Casellato
Giorgio Bozzini
Carlo Marenghi
Alberto Macchi
Luca Lunelli
Barbara Rubino
Claudio Clemente
Publication date
01-07-2012
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2012
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-011-9492-6

Other articles of this Issue 3/2012

Pathology & Oncology Research 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine